Comparing two blood thinners for brain vein clots
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two blood thinners (dabigatran and apixaban) to see which works better for treating a blood clot in the brain's veins. It might help you if you have a new diagnosis of this type of clot and can take oral blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a blood clot in the veins of your brain (cerebral venous thrombosis) within the last 14 days.
- You are able to take blood thinners by mouth.
- You are not pregnant or breastfeeding.
- You do not have a bleeding disorder or a condition that prevents safe use of blood thinners.
- You are not taking certain other medications that interfere with these blood thinners (like some seizure meds or HIV drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood thinners (dabigatran and rivaroxaban) to see which works better for treating a blood clot in the brain's veins. You may be eligible if you have a new diagnosis of this type of stroke and can start treatment within 14 days.
This trial tests a minimally invasive procedure to remove blood clots from veins in the brain (cerebral venous sinus thrombosis). If you've had symptoms like severe headache, seizures, or weakness within the past 3 weeks and imaging confirms a clot, this study may help restore blood flow and prevent serious complications.
This trial compares two blood thinners, Rivaroxaban and Apixaban, to see which works better for people with a blood clot in a brain vein. It may help find the safest and most effective treatment for this condition.
This trial is testing two blood thinners (edoxaban and apixaban) to see how they compare in preventing new brain spots on MRI after a stroke in people with atrial fibrillation. It may help you and your doctor choose the safer option.
This trial tests whether adding a medication called batroxobin to standard blood thinners can help treat blood clots in the veins of the brain better than blood thinners alone. It is for people who have been diagnosed in the last month and are not at high risk for bleeding.
This trial tests two blood thinner medicines, edoxaban and rivaroxaban, in Chinese patients with a blood clot in a brain vein (cerebral venous thrombosis). It aims to see if these medicines are safe and work well.
Hear when a new Cerebral Venous Sinus Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.